(Q40085251)

17 September 2017

title

CD49d expression in chronic lymphocytic leukemia: a prognostic parameter and a therapeutic target (English)

1 reference

chronic lymphocytic leukemia

17 September 2017

0 references

1 reference

2

Gianluca Gaidano

1 reference

17 September 2017

Giovanni Del Poeta

3

1 reference

ORCID Public Data File 2021

Pietro Bulian

series ordinal

1

object named as

Pietro Bulian

1 reference

17 September 2017

4

Valter Gattei

1 reference

17 September 2017

language of work or name

English

0 references

publication date

1 June 2008

1 reference

17 September 2017

1 reference

17 September 2017

volume

4

1 reference

17 September 2017

issue

3

1 reference

17 September 2017

page(s)

355-358

1 reference

CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.3.355

Genomic aberrations and survival in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.3.355

CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.3.355

Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.3.355

The chemokine receptor CCR7 and alpha4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.3.355

ZAP-70 expression and prognosis in chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.3.355

CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.3.355

Alpha4 integrins and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.3.355

RUNX3 regulates the activity of the CD11a and CD49d integrin gene promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.3.355

Maturation-dependent expression and function of the CD49d integrin on monocyte-derived human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.3.355

Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.3.355

Melanoma complicating treatment with natalizumab for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.3.355

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.3.355

CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.3.355

21 January 2018

Identifiers

DOI

10.2217/14796694.4.3.355

1 reference

17 September 2017

1 reference